Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A reduced-dose recombinant pertussis vaccine booster in Thai adolescents: a phase 2/3, observer-blinded, randomised controlled, non-inferiority trial.
Puthanakit T, Tangsathapornpong A, Anugulruengkitt S, Nantanee R, Bunjoungmanee P, Mansouri S, Fortuna L, Wijagkanalan W, Tantawichien T; TDA205 study team. Puthanakit T, et al. Among authors: tangsathapornpong a. Lancet Child Adolesc Health. 2024 Dec;8(12):900-909. doi: 10.1016/S2352-4642(24)00173-1. Lancet Child Adolesc Health. 2024. PMID: 39572123 Clinical Trial.
Population Attributable Risk of Wheeze in 2-<6-Year-old Children, Following a Respiratory Syncytial Virus Lower Respiratory Tract Infection in The First 2 Years of Life.
Madhi SA, Ceballos A, Cousin L, Domachowske JB, Langley JM, Lu E, Puthanakit T, Rämet M, Tan A, Zaman K, Anspach B, Bueso A, Cinconze E, Colas JA, D'Andrea U, Dieussaert I, Englund JA, Gandhi S, Jose L, Karhusaari H, Kim JH, Klein NP, Laajalahti O, Mithani R, Ota MOC, Pinto M, Silas P, Stoszek SK, Tangsathapornpong A, Teeratakulpisarn J, Virta M, Cohen RA. Madhi SA, et al. Among authors: tangsathapornpong a. Pediatr Infect Dis J. 2024 Jul 1. doi: 10.1097/INF.0000000000004447. Online ahead of print. Pediatr Infect Dis J. 2024. PMID: 38985986
Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged children.
Saraban K, Suntarattiwong P, Chantasrisawad N, Boonsathorn S, Kosalaraksa P, Phongsamart W, Tangsathapornpong A, Jaruampornpan P, Srisarang S, Puthanakit T; KIDSVAX study team. Saraban K, et al. Among authors: tangsathapornpong a. Vaccine X. 2023 Nov 24;15:100414. doi: 10.1016/j.jvacx.2023.100414. eCollection 2023 Dec. Vaccine X. 2023. PMID: 38090644 Free PMC article.
Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants.
Lokanuwatsatien T, Satdhabudha A, Tangsathapornpong A, Bunjoungmanee P, Sinlapamongkolkul P, Chaiyakulsil C, Sritipsukho P, Tantiyavarong P. Lokanuwatsatien T, et al. Among authors: tangsathapornpong a. Front Pediatr. 2023 May 24;11:1127582. doi: 10.3389/fped.2023.1127582. eCollection 2023. Front Pediatr. 2023. PMID: 37292374 Free PMC article.
Prevalence, risk factors, and vaccine effectiveness of COVID-19 infection in thai children, adolescents, and young adults in the omicron era.
Chaiyakulsil C, Sritipsukho P, Satdhabudha A, Bunjoungmanee P, Tangsathapornpong A, Sinlapamongkolkul P, Sritipsukho N. Chaiyakulsil C, et al. Among authors: tangsathapornpong a. Front Pediatr. 2023 May 10;11:1173162. doi: 10.3389/fped.2023.1173162. eCollection 2023. Front Pediatr. 2023. PMID: 37234858 Free PMC article.
Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children.
Englund JA, Cohen RA, Bianco V, Domachowske JB, Langley JM, Madhi SA, Zaman K, Bueso A, Ceballos A, Cousin L, Gandhi S, Gruselle O, Jose L, Klein NP, Koen A, Puthanakit T, Shi M, Silas P, Tangsathapornpong A, Teeratakulpisarn J, Vesikari T, Haars G, Leach A, Stoszek SK, Dieussaert I. Englund JA, et al. Among authors: tangsathapornpong a. J Pediatric Infect Dis Soc. 2023 May 31;12(5):273-281. doi: 10.1093/jpids/piad028. J Pediatric Infect Dis Soc. 2023. PMID: 37142551 Free PMC article.
Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine.
Tangsathapornpong A, Nanthapisal S, Pontan K, Bunjoungmanee P, Neamkul Y, Boonyarangkul A, Wanpen S, Fukpho W, Jitpokasem S, Tharabenjasin P, Jaru-Ampornpan P. Tangsathapornpong A, et al. Vaccines (Basel). 2023 Feb 27;11(3):553. doi: 10.3390/vaccines11030553. Vaccines (Basel). 2023. PMID: 36992137 Free PMC article.
Dengue amid COVID-19 pandemic.
Tangsathapornpong A, Thisyakorn U. Tangsathapornpong A, et al. PLOS Glob Public Health. 2023 Feb 6;3(2):e0001558. doi: 10.1371/journal.pgph.0001558. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 36962879 Free PMC article.
The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.
Chantasrisawad N, Techasaensiri C, Kosalaraksa P, Phongsamart W, Tangsathapornpong A, Jaru-Ampornpan P, Sophonphan J, Suntarattiwong P, Puthanakit T; KIDSVAX study team. Chantasrisawad N, et al. Among authors: tangsathapornpong a. Int J Infect Dis. 2023 May;130:52-59. doi: 10.1016/j.ijid.2023.02.017. Epub 2023 Feb 24. Int J Infect Dis. 2023. PMID: 36841501 Free PMC article. Clinical Trial.
34 results